This nonrandomized clinical trial evaluates maximal ablative irradiation because of encasement in patients with locally advanced pancreatic cancer.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Recalibrating “Unresectable” in Pancreatic Cancer | 0 | 12.62 | 01-09-2026 |
| 2 | Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer | 0 | 6.4 | 01-09-2026 |
| 3 | FLOT vs CROSS in Esophageal Adenocarcinoma | 0 | 6.05 | 01-09-2026 |
| 4 | Lumpectomy Margins and Local Recurrence in DCIS | 0 | 8.55 | 01-09-2026 |
| 5 | Clinical trial to treat rectal cancer spares major surgery | 0 | 8.49 | 24-08-2026 |
| 6 | Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer | 0 | 7.48 | 23-09-2026 |
| 7 | Perioperative Toripalimab in Stage III Non–Small Cell Lung Cancer | 0 | 14.35 | 01-09-2026 |
| 8 | FLOT-Induced vs CROSS-Induced Pathological Complete Response | 0 | 8.96 | 01-09-2026 |
| 9 | Q&A: Combining diagnosis, staging, tumor localization and surgery into a minimally invasive procedure for lung cancer | 0 | 6.9 | 02-09-2026 |
| 10 | Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working | 0 | 7.97 | 30-09-2026 |